These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 32782602)

  • 1. High expression of
    Lin B; Zhang T; Ye X; Yang H
    Oncol Lett; 2020 Sep; 20(3):2840-2854. PubMed ID: 32782602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 3. FUT7 Promotes the Epithelial-Mesenchymal Transition and Immune Infiltration in Bladder Urothelial Carcinoma.
    Liu M; Zheng Q; Chen S; Liu J; Li S
    J Inflamm Res; 2021; 14():1069-1084. PubMed ID: 33790621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and immunological role of Fam20C in pan-cancer.
    Liu X; Zhan Y; Xu W; Liu X; Geng Y; Liu L; Da J; Wang J; Zhang X; Jin H; Liu Z; Guo S; Zhang B; Li Y
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33306121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma.
    Zhou Z; Zhou Y; Liu W; Dai J
    Front Genet; 2023; 14():1148430. PubMed ID: 37065485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLAUR as a Potential Biomarker Associated with Immune Infiltration in Bladder Urothelial Carcinoma.
    Liu M; Chen S; Zhang A; Zheng Q; Fu J
    J Inflamm Res; 2021; 14():4629-4641. PubMed ID: 34552345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA.
    Ding Y; Liu N; Chen M; Xu Y; Fang S; Xiang W; Hua X; Chen G; Zhong Y; Yu H
    World J Surg Oncol; 2021 Apr; 19(1):133. PubMed ID: 33888142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
    Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P
    Front Immunol; 2023; 14():955949. PubMed ID: 37006317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma.
    Ni W; Yi L; Dong X; Cao M; Zheng J; Wei Q; Yuan C
    Sci Rep; 2023 Feb; 13(1):2051. PubMed ID: 36739300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HYAL3 as a potential novel marker of BLCA patient prognosis.
    Liu JP; Fang YT; Jiang YF; Lin H
    BMC Genom Data; 2022 Aug; 23(1):63. PubMed ID: 35945500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer.
    Chen R; Jiang M; Hu B; Fu B; Sun T
    Int J Gen Med; 2023; 16():707-722. PubMed ID: 36872941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of SNCA and its methylation in bladder cancer.
    Wu Z; Xia C; Zhang C; Yang D; Ma K
    BMC Cancer; 2022 Mar; 22(1):330. PubMed ID: 35346107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis reveals the value of the expression of chromobox family members for bladder urothelial carcinoma prognosis.
    Meng X; Cao R; Liu X; Fu B; Luo L; Jiang M; Wang K; Liu Y; Zhu Q; Yang C; Zhou L
    Oncol Lett; 2023 Apr; 25(4):172. PubMed ID: 36970607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Signature GXYLT2 Is Correlated with Immune Infiltration in Bladder Cancer.
    Wu S; Qiu S; Chen W; Ding L; Wu L
    Dis Markers; 2022; 2022():5081413. PubMed ID: 36263004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of PTCD1 in Bladder Urothelial Carcinoma Predicts Poor Prognosis and Levels of Immune Infiltration.
    Zhou Z; Zhou Y; Zhou X; Huang Y; Cui Y; Zhang Y
    J Oncol; 2022; 2022():1146186. PubMed ID: 35799606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated transcriptome analysis of CSE1L regarding poor prognosis and immune infiltration in bladder urothelial carcinoma and experimental verification.
    Liu R; Ma J; Zhang Y; Zhou Z
    Front Immunol; 2024; 15():1449251. PubMed ID: 39430746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of RAC3 in bladder cancer predicts adverse clinical outcome and increased tumor immune response.
    Ou-Yang S; Liu JH; Wang QZ
    Int J Clin Exp Pathol; 2020; 13(12):2937-2949. PubMed ID: 33425095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder.
    Zhu L; Liu X; Zhang W; Hu H; Wang Q; Xu K
    BMC Cancer; 2022 May; 22(1):556. PubMed ID: 35581573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.